Study for the Cengage Microbiology Test with helpful multiple choice questions and detailed explanations. Ace your exam with confidence!

Multiple Choice

Which of the following factors should be considered when prescribing an antibiotic for pneumonia?

Choosing an antibiotic for pneumonia requires considering how sick the patient is, what antibiotics they've recently used, and the care setting in which they're being treated. The clinical condition guides how urgently treatment is needed, whether the patient should be hospitalized, and what level of drug breadth and route is appropriate; a severely ill patient or one with organ dysfunction may need IV therapy and broader coverage, while milder cases can often be managed with oral therapy as an outpatient. Prior antibiotic exposure informs the likelihood of resistant organisms; recent use increases the chance that common first-line drugs won’t be effective, so you may choose an agent with activity against resistant strains or different drug classes and plan for de-escalation as soon as cultures are available. The clinical setting defines which pathogens are most probable and what resistance patterns are common; community-acquired pneumonia often involves different organisms and resistance risks than hospital- or healthcare-associated pneumonia, and local antibiograms help tailor empiric therapy. Together these factors guide not only the initial choice but also subsequent narrowing of therapy once results are known. All of these factors matter to select an effective and safe antibiotic while avoiding unnecessary broad-spectrum use.

Choosing an antibiotic for pneumonia requires considering how sick the patient is, what antibiotics they've recently used, and the care setting in which they're being treated. The clinical condition guides how urgently treatment is needed, whether the patient should be hospitalized, and what level of drug breadth and route is appropriate; a severely ill patient or one with organ dysfunction may need IV therapy and broader coverage, while milder cases can often be managed with oral therapy as an outpatient. Prior antibiotic exposure informs the likelihood of resistant organisms; recent use increases the chance that common first-line drugs won’t be effective, so you may choose an agent with activity against resistant strains or different drug classes and plan for de-escalation as soon as cultures are available. The clinical setting defines which pathogens are most probable and what resistance patterns are common; community-acquired pneumonia often involves different organisms and resistance risks than hospital- or healthcare-associated pneumonia, and local antibiograms help tailor empiric therapy. Together these factors guide not only the initial choice but also subsequent narrowing of therapy once results are known. All of these factors matter to select an effective and safe antibiotic while avoiding unnecessary broad-spectrum use.